Answers are grounded in this paper and cite their sources.
Cyclophilin‐B (CypB) is overexpressed in pancreatic cancer, thus, the potential screening of CypB in biofluids and tissue samples may boost the identification of early‐stage pancreatic cancer. A novel strategy of CypB detection utilizing the molecularly imprinted polymer platform, comprising higher binding affinity exhibiting cavities against the CypB protein was developed. Specifically, a nanocatalyst consisting of Pt single atom (Pt sa )‐doped selenium disulfide (SeS 2 )/Ti 3 CNT x MXene nanocomposite is designed. The sluggish diffusion of Pt sa caused by the highest migration energy barrier of 6.39 eV unveils exceptionally high stability (2.89 ×10 88 d (300 K) and 1.053 × 10 24 d (750 K)) with (SeS 2 )/Ti 3 CNT x surface. The Pt sa boosted charge transfer kinetics paves the improved performance of the CypB sensor, while SeS 2 /Ti 3 CNT x supports the stable current density overall. The system establishes a dynamic linear range from 0.12 to 250 n m of CypB detection which correlates with the physiological existence of the CypB in human biofluids and tissues and the excellent detection limit of 80 p m . The liquid chromatography integrated mass spectrometer investigation warranted the significant enhancement of CypB associates with the progression of pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Selvam et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: